Breast Cancer Trials - Australia and New Zealand
Breast Cancer Trials (BCT) is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand with a commitment to exploring and finding better treatments for people affected by breast cancer.
Founded in 1978, BCT conducts a multi-centre national and international clinical trials research program which involves more than 980 researchers in 118 institutions across Australia and New Zealand. More than 17,481 people have participated in our 93 clinical trials.
Our research involves a unique collaboration between researchers, clinical trial participants and supporters, which has improved the treatment of breast cancer, led to changes in the way breast cancer is managed and has saved millions of lives through research collaboration.
Together we are grounded by one simple belief: We can and we will find new and better treatments and prevention strategies for every person affected by breast cancer that saves lives today, tomorrow and forever.
Role
Breast Cancer Trials (BCT) will contribute to this global collaboration by coordinating the conduct OPTIMA-YOUNG within Australian and New Zealand throughout its extensive network of member institutions, and provide strong scientific contribution to the OPTIMA-YOUNG and PATH4Young working groups and steering committees
Members
Dr Belinda Kiely
Dr Belinda Kiely is a medical oncologist specialising in the treatment of breast cancer, with a focus on clinical research to improve symptoms and side effects associated with cancer and its treatment. She holds over 15 years of clinical experience and is a senior lecturer at the University of Sydney, with clinical roles at Campbelltown Hospital and Concord Hospital in Sydney.
Dr Kiely’s research focuses on breast cancer treatment, prognostication and survivorship. She served on the Advanced Breast Cancer International Consensus panel in 2019 and 2023, helping to establish guidelines for managing advanced breast cancer. Her research interests include breast cancer treatment, prognostication, survivorship, and the management of menopausal symptoms in women with breast cancer.
Dr Kiely is the Brest Cancer Trials study chair of the OPTIMA trial and OPTIMA-Young clinical trials.